Skip to main content

Diabetes Severity Tied to Outcome in CRC Patients Undergoing Resection

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Oct. 23, 2023 -- The severity of diabetes is associated with outcomes among patients with stage I to III colorectal cancer (CRC) undergoing curative radical resection, according to a study published online Oct. 23 in Cancer.

Hsin-Yin Hsu, M.D., from the Taipei MacKay Memorial Hospital in Taiwan, and colleagues conducted a population-based retrospective cohort study using data registered between 2007 and 2015 in the Cancer Registry Database, which is linked to the National Health Insurance Research Database and National Death Registry. Patients with CRC who underwent curative radical resection for stage I to III disease were evaluated and subdivided according to diabetic status. The association between diabetes severity and CRC survival was examined.

Data were included for 59,202 patients with CRC. The researchers found that the group with diabetes without complications had insignificantly worse overall survival, disease-free survival, and cancer-specific survival compared with the no diabetes group, while the group with diabetes with complications had a significantly higher risk for poor survival. Compared with those without diabetes, patients with CRC and diabetes had a higher risk for recurrence. Important effect modifiers included sex and TNM staging.

"These findings indicate that preventing diabetes complications may help improve survival in patients with CRC," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

Diagnosis of Early-Onset Colorectal Cancer Often Delayed

WEDNESDAY, May 29, 2024 -- Nearly half of individuals diagnosed with early-onset colorectal cancer (EOCRC) present with hematochezia and abdominal pain, and one-quarter present...

Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation

WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.